This will be a long term winner IMO. Those with money in the stock have all done their research hopefully and are aware this is a highly de-risked pre-approval pharmaceutical play as noted by many including professional investors such as 51 Capital.
If another small delay of IND approval due the FDA being overwhelmed brings an SP drop then I will be happy to take cheap shares from others or short sellers.
Either way I suggest people make the call when they have looked at all the available information and stop fretting. Life is too short to waste your energy on pointless worrying.
GLTAH
Ann: Trading Halt, page-65
-
- There are more pages in this discussion • 254 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.020(8.33%) |
Mkt cap ! $90.94M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 26.0¢ | 24.5¢ | $195.9K | 781.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 38000 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 102892 | 9 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |